Victory Capital Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$331M Buy
1,523,989
+13,939
+0.9% +$3.09M 0.21% 108
2025
Q4
$345M Sell
1,510,050
-15,582
-1% -$3.55M 0.19% 116
2025
Q3
$351M Buy
1,525,632
+120,490
+9% +$24.5M 0.21% 110
2025
Q2
$261M Sell
1,405,142
-24,253
-2% -$4.51M 0.17% 144
2025
Q1
$299M Sell
1,429,395
-455,476
-24% -$88.5M 0.31% 66
2024
Q4
$335M Sell
1,884,871
-63,928
-3% -$11.8M 0.33% 63
2024
Q3
$385M Sell
1,948,799
-166,072
-8% -$31M 0.37% 46
2024
Q2
$363M Buy
2,114,871
+8,754
+0.4% +$1.45M 0.36% 53
2024
Q1
$384M Buy
2,106,117
+151,225
+8% +$26.1M 0.37% 58
2023
Q4
$303M Buy
1,954,892
+241,237
+14% +$35.2M 0.32% 75
2023
Q3
$255M Buy
1,713,655
+2,240
+0.1% +$329K 0.29% 84
2023
Q2
$231M Sell
1,711,415
-48,371
-3% -$7.09M 0.25% 95
2023
Q1
$280M Sell
1,759,786
-474,598
-21% -$72.6M 0.32% 73
2022
Q4
$361M Sell
2,234,384
-29,955
-1% -$4.59M 0.42% 42
2022
Q3
$304M Sell
2,264,339
-109,094
-5% -$15.7M 0.35% 53
2022
Q2
$364M Sell
2,373,433
-421,047
-15% -$64.3M 0.41% 27
2022
Q1
$422M Buy
2,794,480
+196,208
+8% +$28.5M 0.42% 30
2021
Q4
$352M Buy
2,598,272
+231,399
+10% +$27.3M 0.32% 53
2021
Q3
$255M Buy
2,366,873
+251,631
+12% +$28.8M 0.25% 88
2021
Q2
$238M Buy
2,115,242
+525,266
+33% +$59.2M 0.23% 99
2021
Q1
$172M Buy
1,589,976
+115,412
+8% +$12.3M 0.18% 131
2020
Q4
$158M Sell
1,474,564
-37,599
-2% -$3.61M 0.18% 137
2020
Q3
$132M Sell
1,512,163
-20,380
-1% -$1.92M 0.17% 145
2020
Q2
$150M Sell
1,532,543
-2,156,933
-58% -$190M 0.2% 115
2020
Q1
$281M Buy
3,689,476
+1,245,837
+51% +$106M 0.24% 96
2019
Q4
$216M Sell
2,443,639
-116,997
-5% -$9.71M 0.26% 77
2019
Q3
$194M Buy
2,560,636
+1,967,910
+332% +$135M 0.25% 90
2019
Q2
$43.1M Buy
592,726
+458,809
+343% +$36.1M 0.09% 362
2019
Q1
$10.8M Sell
133,917
-184,559
-58% -$15.1M 0.02% 717
2018
Q4
$29.4M Sell
318,476
-13,758
-4% -$1.21M 0.07% 433
2018
Q3
$31.4M Buy
332,234
+170,600
+106% +$16.2M 0.06% 486
2018
Q2
$15M Buy
161,634
+118,089
+271% +$11.5M 0.03% 677
2018
Q1
$4.12M Sell
43,545
-138,079
-76% -$15.2M 0.01% 858
2017
Q4
$17.6M Sell
181,624
-61,279
-25% -$5.78M 0.04% 608
2017
Q3
$21.6M Buy
242,903
+69,923
+40% +$5.32M 0.05% 563
2017
Q2
$12.5M Buy
172,980
+11,773
+7% +$791K 0.03% 670
2017
Q1
$10.5M Buy
161,207
+68,690
+74% +$4.32M 0.03% 688
2016
Q4
$5.79M Sell
92,517
-26,798
-22% -$1.64M 0.01% 757
2016
Q3
$7.53M Buy
119,315
+24,535
+26% +$1.59M 0.02% 704
2016
Q2
$5.87M Buy
94,780
+5,126
+6% +$312K 0.02% 548
2016
Q1
$5.12M Buy
89,654
+27,549
+44% +$1.54M 0.02% 557
2015
Q4
$3.68M Buy
62,105
+61,521
+10,534% +$3.54M 0.02% 574
2015
Q3
$32K Hold
584
﹤0.01% 1558
2015
Q2
$39K Sell
584
-2,136
-79% -$139K ﹤0.01% 1554
2015
Q1
$159K Sell
2,720
-157,709
-98% -$9.53M ﹤0.01% 795
2014
Q4
$10.5M Buy
+160,429
New +$10.1M 0.04% 475
2014
Q2
Sell
-584
Closed -$30K 869
2014
Q1
$30K Buy
+584
New +$29.5K ﹤0.01% 787
2013
Q4
Sell
-1,010
Closed -$45K 912
2013
Q3
$45K Buy
+1,010
New +$44.8K ﹤0.01% 852

Other funds holding ABBV

Victory Capital Management's ABBV Position: Q1 2026 in Review

Victory Capital Management increased its AbbVie (ABBV) stake by 0.92% in Q1 2026, buying an estimated $3.09M and bringing the position to 1,523,989 shares worth $331M. The position accounts for 0.21% of the portfolio, ranked #108.

Victory Capital Management first reported a position in ABBV in Q3 2013 and has held it in 48 quarters since. The position peaked at $422M in Q1 2022. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Victory Capital Management held 1,523,989 shares of AbbVie worth $331M as of Q1 2026.
  • Victory Capital Management bought 13,939 AbbVie shares in Q1 2026, an estimated $3.09M.
  • AbbVie made up 0.21% of Victory Capital Management's portfolio in Q1 2026, its #108 holding.
  • Victory Capital Management first reported a position in AbbVie in Q3 2013 and has held it in 48 quarters since.
  • Victory Capital Management's AbbVie position peaked at $422M in Q1 2022.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Victory Capital Management's 13F filing for Q1 2026, filed 15 May 2026.